DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,481,924 | -0.9% | 170,217 | +2.5% | 0.09% | +2.4% |
| Q2 2023 | $39,834,027 | +10.2% | 166,049 | +15.7% | 0.08% | +1.2% |
| Q1 2023 | $36,160,411 | -0.9% | 143,539 | +4.4% | 0.08% | -11.6% |
| Q4 2022 | $36,504,847 | +33.7% | 137,492 | +30.2% | 0.10% | +30.1% |
| Q3 2022 | $27,299,000 | +21.4% | 105,568 | +19.0% | 0.07% | +28.1% |
| Q2 2022 | $22,494,000 | -52.1% | 88,726 | -44.6% | 0.06% | +14.0% |
| Q1 2022 | $46,950,000 | -3.8% | 160,054 | +7.8% | 0.05% | -51.9% |
| Q4 2021 | $48,810,000 | +20.1% | 148,503 | +11.3% | 0.10% | +1.0% |
| Q3 2021 | $40,625,000 | -6.5% | 133,441 | -17.6% | 0.10% | -14.9% |
| Q2 2021 | $43,467,000 | +206.9% | 161,971 | +157.4% | 0.12% | +146.9% |
| Q1 2021 | $14,161,000 | -57.0% | 62,915 | -57.6% | 0.05% | -59.8% |
| Q4 2020 | $32,955,000 | +15.8% | 148,345 | +11.9% | 0.12% | -14.1% |
| Q3 2020 | $28,470,000 | +251.1% | 132,533 | +189.0% | 0.14% | +189.8% |
| Q2 2020 | $8,109,000 | -15.5% | 45,863 | -33.8% | 0.05% | -34.7% |
| Q1 2020 | $9,591,000 | -14.1% | 69,294 | -4.8% | 0.08% | +8.7% |
| Q4 2019 | $11,170,000 | +90.8% | 72,778 | +79.6% | 0.07% | +68.3% |
| Q3 2019 | $5,853,000 | -12.5% | 40,525 | -13.4% | 0.04% | -10.9% |
| Q2 2019 | $6,690,000 | +67.7% | 46,813 | +54.9% | 0.05% | +58.6% |
| Q1 2019 | $3,989,000 | +296.1% | 30,224 | +209.5% | 0.03% | +222.2% |
| Q4 2018 | $1,007,000 | -23.4% | 9,767 | -19.3% | 0.01% | -10.0% |
| Q3 2018 | $1,315,000 | +430.2% | 12,100 | +381.1% | 0.01% | +233.3% |
| Q2 2018 | $248,000 | +1.6% | 2,515 | +0.8% | 0.00% | 0.0% |
| Q1 2018 | $244,000 | -10.6% | 2,496 | -15.1% | 0.00% | -25.0% |
| Q4 2017 | $273,000 | +8.3% | 2,941 | -0.5% | 0.00% | -20.0% |
| Q3 2017 | $252,000 | -91.4% | 2,955 | -91.5% | 0.01% | -90.2% |
| Q2 2017 | $2,931,000 | -30.4% | 34,745 | -29.4% | 0.05% | -35.4% |
| Q1 2017 | $4,209,000 | +59.0% | 49,214 | +44.7% | 0.08% | +33.9% |
| Q4 2016 | $2,648,000 | -0.9% | 34,013 | -0.2% | 0.06% | +7.3% |
| Q3 2016 | $2,671,000 | +21.8% | 34,084 | +21.7% | 0.06% | -3.5% |
| Q2 2016 | $2,193,000 | -17.5% | 28,013 | 0.0% | 0.06% | -20.8% |
| Q1 2016 | $2,657,000 | +0.9% | 28,013 | -1.1% | 0.07% | -17.2% |
| Q4 2015 | $2,633,000 | +1172.0% | 28,336 | +1066.1% | 0.09% | +987.5% |
| Q3 2015 | $207,000 | -6.3% | 2,430 | -6.0% | 0.01% | +14.3% |
| Q2 2015 | $221,000 | +1.4% | 2,585 | +0.8% | 0.01% | 0.0% |
| Q1 2015 | $218,000 | -77.2% | 2,564 | -78.9% | 0.01% | -66.7% |
| Q2 2014 | $957,000 | +6.8% | 12,161 | +1.8% | 0.02% | -8.7% |
| Q1 2014 | $896,000 | -39.3% | 11,949 | -37.5% | 0.02% | -62.9% |
| Q4 2013 | $1,477,000 | +14.4% | 19,128 | +2.7% | 0.06% | +6.9% |
| Q3 2013 | $1,291,000 | -10.3% | 18,618 | -18.1% | 0.06% | -23.7% |
| Q2 2013 | $1,439,000 | +74.6% | 22,731 | +43.6% | 0.08% | +58.3% |
| Q2 2012 | $824,000 | -9.8% | 15,827 | -3.0% | 0.05% | -2.0% |
| Q1 2012 | $914,000 | +24.4% | 16,315 | +4.4% | 0.05% | -23.4% |
| Q4 2011 | $735,000 | -0.4% | 15,624 | -11.2% | 0.06% | -7.2% |
| Q3 2011 | $738,000 | -32.7% | 17,603 | -14.9% | 0.07% | -19.8% |
| Q2 2011 | $1,096,000 | – | 20,680 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |